Seeking Alpha

Landmark Study Demonstrates Sustained Clinical Benefits of Flexitouch® Plus as First-Line Therapy in Treating Head and Neck Cancer-Related Lymphedema

MINNEAPOLIS, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the ...
Yahoo Finance

New Data Demonstrates Significant Clinical and Quality-of-Life Benefits of Flexitouch® Plus in Treating Lymphedema Among Head and Neck Cancer Survivors

MINNEAPOLIS, June 03, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with ...
The Globe and Mail

Tactile Medical Announces Enrollment of First Patient in Randomized, Controlled Clinical Trial Evaluating the Effectiveness of Flexitouch® Plus for the Treatment of Head and ...

MINNEAPOLIS, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the ...
Nasdaq

Tactile Medical Presents Promising Clinical Data for Flexitouch Plus in Treating Head and Neck Cancer-Related Lymphedema at ASCO 2025 Annual Meeting

Tactile Systems Technology, Inc. announced at the ASCO 2025 Annual Meeting new clinical data showing that its Flexitouch Plus device significantly improves clinical outcomes and quality of life for ...